Travoprost CAS 157283-68-6 Assay 96.0%~102.0% API Factory High Purity

Short Description:

Chemical Name: Travoprost

CAS: 157283-68-6

Appearance: Colorless or Yellowish Oil

Assay: 96.0%~102.0% (anhydrous and solvent free basis)

Travoprost is used to treat glaucoma and ocular hypertension, is a potent and selective FP prostaglandin receptor agonist.

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Commercial Production with High Purity and Stable Quality
Chemical Name: Travoprost
CAS: 157283-68-6
Used to treat glaucoma and ocular hypertension, is a potent and selective FP prostaglandin receptor agonist.

Chemical Properties:

Chemical Name	Travoprost
CAS Number	157283-68-6
CAT Number	RF-API27
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C26H35F3O6
Molecular Weight	500.55
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Colorless or Yellowish Oil
IR	Positive
HPLC	Positive
Specific Rotation [α]20D	+52° ~ +58° (20mg/ml, EtOH 365nm)
Moisture (K.F)	≤1.0%
Related Substances
15-epi Diastereomer	≤0.50%
Epoxide Derivative	≤0.40%
Travoprost Free Acid	≤0.50%
5,6-trans-Travoprost	≤1.0%
Travoprost Methyl Ester	≤0.50%
15-Keto Derivative	≤0.10%
Any Other Impurity	≤0.10%
Total Other Impurities	≤0.50%
Residual Solvents
Acetonitrile	≤0.04%
Ethanol	≤0.50%
n-Hexane	≤0.05%
Assay	96.0%~102.0% (anhydrous and solvent free basis)
Test Standard	Enterprise Standard
Usage	Active Pharmaceutical Ingredient (API)

Package & Storage:

Package: Bottle, Barrel, 25kg/Barrel, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

FAQ:

Application:

Travoprost (CAS 157283-68-6) has the ocular hypotensive efficacy and has the potential for glaucoma and ocular hypertension, is a potent and selective FP prostaglandin receptor agonist.Travoprost was launched in the US as Travatan, an ophthalmic solution (0.004%) administered topically for the treatment of elevated intraocular hypertension (lOP) through open-angle glaucoma, a common optic neuropathy and a leading cause of blindness. Travoprost is the isopropyl ester of (+)-fluprostenol, a new prostaglandin derivative belonging to the PGF2α, analog class. In addition, travoprost was safe and well tolerated with a low incidence of conjunctival hyperaemia.